COMMUNIQUÉS West-GlobeNewswire

OrthoPediatrics Corp. Announces First PNP | FEMUR Cases Performed in Australia

17/09/2018 - 22:01

WARSAW, Ind., Sept. 17, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first [...]

G1 Therapeutics Announces Proposed Offering of Common Stock

17/09/2018 - 22:01

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it has commenced an underwritten public offering of 3,000, [...]

Sanofi: Disclosure of trading in own shares

17/09/2018 - 18:01

Attachment Reporting EN.pdf

Sanofi : Déclaration des transactions sur actions propres

17/09/2018 - 18:01

Pièce jointe Reporting FR.pdf

Ossur Hf : Transactions in relation to share buyback program

17/09/2018 - 18:01

Announcement no. 55/2018 17 September 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]

Virbac : Operating profit up sharply in the first half of 2018

17/09/2018 - 17:46

Operating profit up sharply in the first half of 2018 CONSOLIDATED DATA AS OF JUNE 30 in € million 2018 2017 2018/2017 Evolution Revenue 430.0 437.5 -1.7% Evolution at constant exchange rates +3.9% Evolution at constant [...]

Virbac :Résultat opérationnel du premier semestre 2018 en nette croissance

17/09/2018 - 17:46

Résultat opérationnel du premier semestre 2018 en nette croissance CHIFFRES CONSOLIDÉS AU 30 JUIN en millions € 2018 2017 Évolution 2018/2017 Chiffre d'affaires 430,0 437,5 -1,7% Évolution à taux de change constants +3, [...]

Virbac: Availability of the half-yearly financial report as of June 30, 2018

17/09/2018 - 17:46

Virbac: Availability of the half-yearly financial report as of June 30, 2018 Public release - September 17, 2018 Virbac announced today that the 2018 half-yearly financial report is now available and has been filed with [...]

Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2018

17/09/2018 - 17:46

Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2018 Communiqué diffusé le 17 septembre 2018 La société annonce avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés [...]

Oxurion NV to present further scientific findings supporting therapeutic potential of THR-317 & THR-687 as promising new therapies for Diabetic Eye Disease at upcoming EURETINA 2018 in Vienna, Austria

17/09/2018 - 17:41

Leuven, Belgium, 17 September 2018 - Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases [...]

Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy

17/09/2018 - 16:43

Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on the development of [...]

Advanzeon Solutions Engages Hayden IR to Develop Comprehensive Investor Relations Program

17/09/2018 - 16:38

Focused on Increasing Awareness and Enhancing Shareholder Value TAMPA, Fla., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Advanzeon Solutions, Inc. (OTC: CHCR ) today announced that it has retained Hayden IR , a national investor [...]

CLS Holdings USA Executes Two Letters of Intent, which will provide the Opportunity to Enter the Rapidly Expanding Massachusetts Market

17/09/2018 - 15:38

LAS VEGAS, Sept. 17, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]

Phase 2 Ready Oncology Drug Receives FDA Orphan Drug Designation

17/09/2018 - 15:28

SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced that it received FDA orphan drug designation for its ATI-1123 chemotherapy drug product [...]

Medtronic Joins Catalyst CEO Champions For Change and Pledges to Accelerate Women Into Management and Board Seats

17/09/2018 - 15:16

Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality DUBLIN - September 17, 2018 - Medtronic plc (NYSE:MDT) today announced it has joined the Catalyst CEO Champions For [...]

ATW Tech Signs a Letter of Intent for the Divestiture of Its Atman Assets

17/09/2018 - 15:00

MONTREAL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today that its fully-owned subsidiary InformationTelcharge.com (‘Atman’) signed a letter of intent to divest some of its assets to Marie- [...]

ATW Tech signe une lettre d’intention pour la vente des actifs d’Atman

17/09/2018 - 15:00

MONTRÉAL, 17 sept. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la signature par sa filiale exclusive InformationTelcharge.com (« Atman ») visant la vente de [...]

Comprehensive Pharmacy Services Named Best Pharmacy Support Services Provider – USA

17/09/2018 - 15:00

Global Health and Pharma Recognizes Comprehensive Pharmacy Services in 2018 Healthcare & Pharmaceutical Awards MEMPHIS, Tenn., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Global Health & Pharma (GHP) has selected [...]

Avadim Technologies Announces Name Change To Avadim Health, Inc.

17/09/2018 - 15:00

Name Change To Reflect Company Vision – “To Take Healing To The Nations” ASHEVILLE, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced [...]